Genprex Inc (GNPX)

10:00 AM

Genprex Inc (NASDAQ: GNPX) Stock’s Potential for Success in the Coming Months - Marketing Sentinel

10:00 AM

08:17 AM

Genprex Signs Agreement With New York University Langone Health - marketscreener.com

08:17 AM

07:30 AM

Revolutionary Gene Therapy Shows 84% Target Success in Mesothelioma Treatment: Genprex-NYU Partnership - Stock Titan

07:30 AM

Apr 27, 2025

Short Interest in Genprex, Inc. (NASDAQ:GNPX) Grows By 487.6% - Defense World

Apr 27, 2025

Apr 26, 2025

Stock Market Recap: Genprex Inc (GNPX) Concludes at 0.27, a 0.57 Surge/Decline - DWinneX

Apr 26, 2025

Apr 24, 2025

GNPX’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 24, 2025

Apr 24, 2025

Now Is The Time To Build A Position In Genprex Inc (NASDAQ:GNPX) - Marketing Sentinel

Apr 24, 2025

Apr 24, 2025

Genprex Selected to Present Trial Design of Acclaim-3 Clinical T - GuruFocus

Apr 24, 2025

Apr 24, 2025

Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting - PR Newswire

Apr 24, 2025

Apr 22, 2025

Genprex Inc (GNPX) receives a Buy rating from National Securities - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

Genprex presents promising gene therapy data for lung cancer By Investing.com - Investing.com South Africa

Apr 22, 2025

Apr 22, 2025

How Are Things Looking For Genprex Inc (NASDAQ: GNPX) For The Short Term? - Stocksregister

Apr 22, 2025

Apr 22, 2025

Genprex presents promising gene therapy data for lung cancer - Investing.com

Apr 22, 2025

Apr 22, 2025

There is no doubt that Genprex Inc (GNPX) ticks all the boxes. - Sete News

Apr 22, 2025

Apr 22, 2025

Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings | GNPX Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings - PR Newswire

Apr 22, 2025

Apr 21, 2025

Ratio Examination: Genprex Inc (GNPX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 21, 2025

Apr 20, 2025

Genprex, Inc. (NASDAQ:GNPX) Short Interest Update - Defense World

Apr 20, 2025

Apr 18, 2025

Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer (PR Newswire) - Aktiellt

Apr 18, 2025

Apr 17, 2025

What Analysts Were Expecting After Genprex Inc (NASDAQ: GNPX) fell -1.73% - stocksregister.com

Apr 17, 2025

Apr 12, 2025

Analysts Provide Insight Into Genprex Inc’s (GNPX) Potential. - Stocksregister

Apr 12, 2025

Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 02, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025

Apr 01, 2025

Genprex Delays Yearly Report Filing - TipRanks

Apr 01, 2025

Apr 01, 2025

Genprex Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025

Apr 01, 2025

Genprex, Inc. SEC 10-K Report - TradingView

Apr 01, 2025

Mar 31, 2025

Genprex (GNPX) Projected to Announce Earnings on Monday - Defense World

Mar 31, 2025

Mar 28, 2025

Genprex stock plunges to 52-week low of $0.27 By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Genprex stock plunges to 52-week low of $0.27 - Investing.com India

Mar 28, 2025

Mar 26, 2025

Genprex reports progress in lung cancer gene therapy By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Genprex reports progress in lung cancer gene therapy - Investing.com India

Mar 26, 2025

Mar 26, 2025

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting - PR Newswire

Mar 26, 2025

Mar 25, 2025

Genprex Collaborators Selected to Present Positive Preclinical Data on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions - Quantisnow

Mar 25, 2025

Mar 25, 2025

Game-Changing Gene Therapy Could End Daily Insulin Injections for Diabetes Patients - Stock Titan

Mar 25, 2025

Mar 18, 2025

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 18, 2025

Mar 14, 2025

Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® De - GuruFocus.com

Mar 14, 2025

Mar 13, 2025

Genprex Inc (GNPX) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Mar 13, 2025

Mar 04, 2025

Genprex to Participate at BIO Europe Spring 2025 - StreetInsider.com

Mar 04, 2025

Feb 27, 2025

Genprex to Present at the 2020 LD Micro Virtual Conference - ACCESS Newswire

Feb 27, 2025

Feb 20, 2025

Genprex Strengthens Diabetes Focus with New License - TipRanks

Feb 20, 2025

Feb 19, 2025

Genprex explores non-viral gene therapy for diabetes By Investing.com - Investing.com Nigeria

Feb 19, 2025

Feb 19, 2025

Genprex Advances Diabetes Program With Addition Of Research Focused On Non-Viral Delivery System - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Genprex explores non-viral gene therapy for diabetes - Investing.com India

Feb 19, 2025

Feb 19, 2025

Can This New Delivery System Transform Diabetes Gene Therapy? Genprex's Latest Breakthrough - StockTitan

Feb 19, 2025

Feb 18, 2025

Genprex advances diabetes gene therapy with new license By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

Genprex Provides Update On Diabetes Gene Therapy Program -February 18, 2025 at 10:03 am EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Genprex announces advancement of its diabetes gene therapy program - TipRanks

Feb 18, 2025

Feb 18, 2025

Genprex advances diabetes gene therapy with new license - Investing.com India

Feb 18, 2025

Feb 18, 2025

Genprex Provides Update on Diabetes Gene Therapy Program - Nasdaq

Feb 18, 2025